Digital Health APAC

APAC Chronic Disease Management Apps Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

APAC Chronic Disease Management Apps Market Industry Trends and Forecast to 2034: Segmented by (Condition, Revenue Model, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

APAC · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $1.27 Bn Placeholder estimate
Estimate 2025 $1.50 Bn 18.3% of the global market
Projected 2034 $6.81 Bn 353.8% Adds $5.31 Bn over 9 forecast years
CAGR 2025–2034 18.3% Faster than 56% of 100 Digital Health markets here
Key players 5
  • APAC is 18.27% of the global market.
  • Among regions, the largest is North America at $4.35 Bn.
  • Fastest growing: Africa at 18.6% a year.
  • APAC ranks 2nd of 6 by size among regions.

Market size projection

APAC

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$5.31 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Chronic Disease Management Apps Market market size by year, APAC
YearMarket sizeChange that yearSince 2025
2024 (estimate) $1.27 Bn — —
2025 (base) $1.50 Bn +$232.1 Mn —
2026 (forecast) $1.78 Bn +$274.6 Mn +18.3%
2027 (forecast) $2.10 Bn +$324.9 Mn +39.9%
2028 (forecast) $2.48 Bn +$384.3 Mn +65.6%
2029 (forecast) $2.94 Bn +$454.7 Mn +95.9%
2030 (forecast) $3.48 Bn +$537.9 Mn +131.7%
2031 (forecast) $4.11 Bn +$636.3 Mn +174.1%
2032 (forecast) $4.87 Bn +$752.7 Mn +224.3%
2033 (forecast) $5.76 Bn +$890.5 Mn +283.6%
2034 (forecast) $6.81 Bn +$1.05 Bn +353.8%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

APAC Chronic Disease Management Apps Market Analysis at a glance
Market size, 2025$1.50 Bn placeholder estimate
Forecast, 2034$6.81 Bn placeholder estimate
Growth (CAGR), 2025–203418.3% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsCondition, revenue model and end user (see all)
Key playersOmada Health, Teladoc Health, Welldoc, Dario Health, Hello Heart (see all)
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The APAC Chronic Disease Management Apps Market Analysis Executive Summary

Chronic disease management apps help people manage diabetes, heart disease and other long-term conditions with tracking and coaching.

Key segments of the chronic Disease Management Apps market include condition (Diabetes, Hypertension and Heart Disease) and revenue model (Employer and Payer Paid, Subscription and Prescription).

Bar chart: Asia Pacific Chronic Disease Management Apps market size, 2024–2034, placeholder estimates. $1.27 Bn in 2024, $1.50 Bn in 2025 and $6.81 Bn in 2034, 18.3% CAGR.
Asia Pacific Chronic Disease Management Apps market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

APAC Chronic Disease Management Apps Market Dynamics

Market Growth Drivers

Patients expect online access to their care, providers need to cut admin work, and smartphones are now used by most patients worldwide. These are driving the chronic Disease Management Apps market.

Opportunity

AI assistants, mobile-first design and use in emerging markets give the chronic Disease Management Apps market room to grow.

Market Restraints

Low use by older patients, data privacy concerns, poor integration with records systems and funding pressures hold back the chronic Disease Management Apps market.

Competitive Landscape for Chronic Disease Management Apps Market in APAC

The chronic Disease Management Apps market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Chronic Disease Management Apps Market in APAC

Chronic Disease Management Apps in APAC: rules and payment

In some of the countries we cover here, rules for health software come from TGA (Australia)⁠[1], NMPA (China)⁠[2] and PMDA (Japan)⁠[3]. How care is paid for in some of these countries: Medicare and the PBS (Australia)⁠[4], basic medical insurance (China)⁠[5], the Hospital Authority (Hong Kong)⁠[6], Ayushman Bharat PM-JAY (India)⁠[7], public health insurance (Japan)⁠[8], subsidised public care (Malaysia)⁠[9], Pharmac (New Zealand)⁠[10], PhilHealth (Philippines)⁠[11], MediShield Life (Singapore)⁠[12] and the Universal Coverage Scheme (Thailand)⁠[13].

[1] Therapeutic Goods Administration. Checked 14 Nov 2026.

[2] National Medical Products Administration. Checked 14 Nov 2026.

[3] Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.

[4] Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.

[5] National Healthcare Security Administration. Checked 14 Nov 2026.

[6] Hospital Authority. Checked 14 Nov 2026.

[7] National Health Authority (PM-JAY). Checked 14 Nov 2026.

[8] Ministry of Health, Labour and Welfare. Checked 14 Nov 2026.

[9] Ministry of Health Malaysia. Checked 14 Nov 2026.

[10] Pharmac. Checked 14 Nov 2026.

[11] PhilHealth. Checked 14 Nov 2026.

[12] CPF Board, MediShield Life. Checked 14 Nov 2026.

[13] National Health Security Office. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Rules on software as a medical device, data privacy (such as HIPAA and GDPR) and telehealth reimbursement shape the chronic Disease Management Apps market. Government digital health programs in APAC are speeding up adoption.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Chronic Disease Management Apps right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Chronic Disease Management Apps in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Chronic Disease Management Apps market in Asia Pacific?
Placeholder estimate: about $1.50 Bn in 2025, rising to about $6.81 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Chronic Disease Management Apps market in Asia Pacific growing?
Placeholder estimate: about 18.3% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Chronic Disease Management Apps market report cover?
The report splits the market by condition (Diabetes, Hypertension, Heart Disease, Respiratory Diseases), revenue model (Employer and Payer Paid, Subscription, Prescription) and end user (Healthcare Providers, Patients, Payers, Pharmaceutical Companies).
Who are the key players in the Chronic Disease Management Apps market?
Key players include Omada Health, Teladoc Health, Welldoc, Dario Health and Hello Heart.
What is driving the Chronic Disease Management Apps market?
Patients expect online access to their care, providers need to cut admin work, and smartphones are now used by most patients worldwide. These are driving the chronic Disease Management Apps market.
How much research is published on Chronic Disease Management Apps?
PubMed lists 232 papers on Chronic Disease Management Apps added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Digital Health reports in APAC

See all

Related on digital health and diabetes

See the topic